Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

BetterLife Pharma Inc C.BETR

Alternate Symbol(s):  BETRF

Healthcare Biotechnology
BetterLife Pharma Inc., a biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight viral infections. The company’s products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety disorder, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat anxiety related disorders, including benzodiazepine dependency. It is also developing MM-001, a topical cream formulation of interferon-alpha 2b, which has completed Phase II clinical trials for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalation formulation that has completed Phase II clinical trials for the treatment of COVID-19 and other...


CSE:BETR - Post by User

BetterLife Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(564)
•••
  • rixpixX
Post by rixpixon Jul 03, 2024 8:58am
215 Views
Post# 36115961

Must be ignorant to believe there are no shares for sale

Must be ignorant to believe there are no shares for saleSome people want to believe there are hardly any shares for sale. They are either ignorant or extremely gullible.

Just because there are not many shares for sale on the board doesn't mean there are no sellers waiting on the sides.

I really believe there are millions of shares for sale between here and 15cents even though they are not showing up in the market depth board. MILLIONS! 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities